Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).

Engstrom, P F

Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278). [electronic resource] - American journal of clinical oncology Aug 1984 - 313-8 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.

0277-3732


Adenocarcinoma--drug therapy
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Clinical Trials as Topic
Colonic Neoplasms--drug therapy
Dacarbazine--therapeutic use
Drug Administration Schedule
Female
Fluorouracil--administration & dosage
Gastrointestinal Diseases--chemically induced
Hematologic Diseases--chemically induced
Humans
Hydroxyurea--therapeutic use
Male
Middle Aged
Mitomycins--therapeutic use
Random Allocation
Razoxane--therapeutic use
Rectal Neoplasms--drug therapy
Semustine--therapeutic use
Time Factors